Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2008.08.070PMID 19117696PMCID PMC2709288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.

  2011cited by this paper
• Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

  2008cited by this paper
• Early Clinical Outcome in Patients Treated for Anal Canal Cancer using Dose-painted Intensity Modulated Radiation Therapy

  2008cited by this paper
• Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.

  2007cited by this paper
• Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer

  2007cited by this paper
• Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.

  2007cited by this paper
• Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans

  2007cited by this paper
• Intensity-modulated radiotherapy with a belly board for rectal cancer

  2007cited by this paper
• Definition and delineation of the clinical target volume for rectal cancer.

  2006cited by this paper
• Chemotherapy with preoperative radiotherapy in rectal cancer.

  2006cited by this paper
• Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels.

  2006cited by this paper
• Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.

  2006cited by this paper
• Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

  2006cited by this paper
• Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

  2006cited by this paper
• Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.

  2005cited by this paper
• Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

  2005cited by this paper
• The relationship between condom use and herpes simplex virus acquisition

  2005cited by this paper
• The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer.

  2004cited by this paper
• Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation

  2004cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.

  2004cited by this paper
• Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancer

  2004cited by this paper
• Technical aspects of image-based treatment planning of rectal carcinoma.

  2003cited by this paper
• The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer

  2002cited by this paper
• The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.

  2002cited by this paper
• The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment.

  2002cited by this paper
• Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study.

  1996cited by this paper
• Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

  1996cited by this paper
• Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08.

  1996cited by this paper
• A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation.

  1986cited by this paper
• Proceedings of the American Society of Clinical Oncology

  1982cited by this paper
• Statistical Methods for Rates and Proportions, 2nd ed

  1981cited by this paper
• The measurement of observer agreement for categorical data.

  1977cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper

• Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy

  2026cites this paper
• Radiation-induced severe lymphopenia predicts distant metastasis in rectal cancer: dosimetric implications for immune-sparing radiotherapy

  2026cites this paper
• CT Attenuation of Bone Predicts Incident Fracture in Patients with Anorectal Cancer Treated with Radiation

  2026cites this paper
• Inguinal CTV contouring in anal cancer: comparative validation of inguinal lymph nodes contouring guidelines and implications for consensus.

  2026cites this paper
• Randomized phase III Study of Adding Paclitaxel to Chemoradiotherapy With Capecitabine and Mitomycin C in Squamous Cell Anal Carcinoma.

  2026cites this paper
• Impact of the risk-adapted Nordic anal cancer group consensus guidelines on the contouring of the elective clinical target volume in anal cancer

  2025cites this paper
• Imaging Features of Anal Carcinoma after Chemoradiation.

  2025cites this paper
• Prospective evaluation of small bowel dose and acute gastrointestinal toxicity during pelvic radiotherapy for gynaecologic malignancies.

  2025cites this paper
• Elective clinical target volume in early squamous cell anal canal cancer: A systematic review and meta-analysis of the risk of recurrence in untreated upper pelvic and external iliac lymph nodes.

  2025cites this paper
• Prognostic Value of External Iliac Lymph Node (N1b) Metastasis in Anal Carcinoma and Validation of a New Stage Grouping System.

  2025cites this paper
• Variations in radiotherapy delineation of the lateral compartments in patients with rectal cancer: results after an updated national guideline.

  2025cites this paper
• Contouring atlas and essential points for radiotherapy in rectal cancer

  2025cites this paper
• Quantifying Interfractional Motion in Patients With Anorectal Cancer During Radiotherapy and Recommendations of Optimal Planning Target Volume Margins

  2025cites this paper
• Treatment response prediction in rectal cancer patients: A radiomics study of multimodality imaging methods.

  2025cites this paper
• Determining optimal GTV‐to‐PGTV margins for CT‐guided dose‐escalated radiotherapy with daily image guidance in locally advanced rectal cancer

  2025cites this paper
• Evaluating the Effect of Co-Registered Diagnostic MR Images Based CT Simulation on Target Volume Delineation and Dose Distribution for Tomotherapy of Rectal Cancer

  2025cites this paper
• Innovative radiotherapy approaches

  2025cites this paper
• Role of radiotherapy in the management of anal canal cancer: Recommendations of the Société française de radiothérapie oncologique.

  2025cites this paper
• Effect of neoadjuvant therapy on textbook outcomes in minimally invasive rectal cancer surgery

  2025influential citation
• Assessing Axis-specific Set-up Errors in Rectal Cancer Radiotherapy: A Prospective Cone-beam Computed Tomography-Based Study with Body Mass Index Correlation

  2025cites this paper
• A feasibility study of sexual organ‐dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three‐dimensional conformal radiation therapy

  2025cites this paper
• Comparison of efficacy and side effects between short-course radiotherapy and chemotherapy with or without immunotherapy in the neoadjuvant treatment for patients with locally advanced rectal cancer

  2025cites this paper
• Treatment Pattern and Outcome of Locally Advanced Rectal Cancer in Resource-Constrained Countries: Experience at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

  2025cites this paper
• Rectal Leiomyosarcoma Treated With Surgery and Adjuvant Radiotherapy: A Case Report With a Brief Review of Radiotherapy Techniques From a Radiation Oncologist’s Perspective

  2025cites this paper
• Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer

  2025cites this paper
• Optimising chemoradiotherapy in anal cancer

  2025cites this paper
• External beam radiation therapy for cell carcinoma of the anal canal: preparation, planning, details of treatment

  2025cites this paper
• Clinical evaluation of atlas-based auto-segmentation for contouring pelvic CTVs in the treatment of anal cancer with FDG-PET-positive lymph node involvement

  2025cites this paper
• Assessment of response to total neoadjuvant therapy in carcinoma rectum: A real-world prospective observational study from eastern India.

  2025cites this paper
• Rectal cancer radiotherapy: 2025 update.

  2025cites this paper
• Comparative evaluation of TNM staging systems (eighth vs. ninth edition) for the non-surgical treatment of localized and locally advanced anal squamous cell carcinoma: Prognostic significance of T classification and lymph node status

  2025cites this paper
• Clear cell sarcoma like tumor of the rectum: A rare entity.

  2025cites this paper
• Prediction of pathological complete response and prognosis in locally advanced rectal cancer

  2024cites this paper
• Is radiotherapy necessary for upper rectal cancer underwent curative resection? A retrospective study of 363 patients

  2024cites this paper
• Lumbosacral plexopathy after short-course neoadjuvant radiotherapy for rectal cancer: A case report.

  2024cites this paper
• Excluding external iliac node irradiation during neoadjuvant radiotherapy decreases lower intestinal toxicity without compromising efficacy in T4b rectal cancer patients with tumours involving the anterior structures

  2024cites this paper
• Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer

  2024cites this paper
• Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer

  2024cites this paper
• Lymphopenia is an adverse prognostic factor in rectal adenocarcinoma patients receiving long-course chemoradiotherapy

  2024cites this paper
• Nonoperative management protocol for locally advanced rectal cancer

  2024cites this paper
• Impact of belly board immobilization devices and body mass factor on setup displacement using daily cone‐beam CT in rectal cancer radiotherapy

  2024cites this paper
• Is the omission of the external iliac or upper pelvic lymph nodes from elective irradiation safe in selected anal canal squamous cell cancers?

  2024cites this paper
• Cross-Sectional National Survey of Practice Patterns in Radiotherapy for Rectal Cancer: A Snapshot of India

  2024cites this paper
• Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus

  2024cites this paper
• Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using 18F-FDG PET/CT

  2024cites this paper
• Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer.

  2024cites this paper
• Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system

  2024cites this paper
• The impact of transanal drainage tube on the incidence of anastomotic leakage and small bowel obstruction in radical surgery (Dixon) for rectal cancer: a retrospective cohort study

  2024cites this paper
• Preventive efficacy of hydrocortisone enema for radiation proctitis in rectal cancer patients undergoing short-course radiotherapy: a phase II randomized placebo-controlled clinical trial

  2024cites this paper
• Short course irradiation in rectal cancer: Dosimetry study comparing 3D conformal radiotherapy versus intensity-modulated radiotherapy versus volumetric modulated arc therapy

  2024cites this paper
• Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH)

  2024cites this paper
• Cross-technique transfer learning for autoplanning in magnetic resonance imaging-guided adaptive radiotherapy for rectal cancer.

  2024cites this paper
• Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial.

  2024cites this paper
• Deep-learning based triple-stage framework for MRI-CT cross-modality gross tumor volume (GTV) segmentation for rectal cancer neoadjuvant radiotherapy

  2024cites this paper
• Clinical outcomes, patterns of failure, and salvage therapies of a large modern cohort of patients with anal squamous cell carcinoma treated with definitive-intent IMRT.

  2024cites this paper
• ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol

  2024cites this paper
• Evaluating complete response prediction rates in locally advanced rectal cancer with different radiomics segmentation approaches

  2024cites this paper
• Identification of patients with locally advanced rectal cancer eligible for neoadjuvant chemotherapy alone: Results of a retrospective study

  2023cites this paper
• Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy

  2023cites this paper
• Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma

  2023cites this paper
• Gender-affirming Surgery and Cancer: Considerations for Radiation Oncologists for Pelvic Radiation in Transfeminine Patients.

  2023cites this paper
• Inguinal nodal clinical target volume delineation based on analysis of anatomical locations of normal and metastatic lymph nodes in pelvic malignant tumors.

  2023cites this paper
• Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancer

  2023cites this paper
• Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients

  2023cites this paper
• Radiation hematologic toxicity prediction for locally advanced rectal cancer using dosimetric and radiomics features

  2023cites this paper
• Lymph Node Metastasis in Extraperitoneal Rectal Cancer After Neoadjuvant Therapy: An Unsolved Problem?

  2023cites this paper
• Evaluation of survival outcomes and prognostic factors of carcinoma anal canal at a tertiary cancer center

  2023cites this paper
• Lateral Pelvic Nodal Management and Patterns of Failure in Patients Receiving Short-Course Radiation for Locally Advanced Rectal Cancer

  2023cites this paper
• Radiological Biomarkers in MRI directed Rectal Cancer Radiotherapy Volume Delineation

  2023cites this paper
• Upper limit of radiation treatment portals in rectal cancer: is it wise to keep using bony landmarks in the present era of 3D conformal treatment?

  2023cites this paper
• Towards deep-learning (DL) based fully automated target delineation for rectal cancer neoadjuvant radiotherapy using a divide-and-conquer strategy: a study with multicenter blind and randomized validation

  2023cites this paper
• Randomized Controlled Trial of Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy Versus Long-Course Chemoradiotherapy in Locally Advanced Rectal Cancer: Comparison of Overall Response Rates

  2023cites this paper
• Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer

  2023cites this paper
• Capecitabine/cisplatin combined with concurrent intensity-modulated radiation therapy: a feasible therapeutic strategy for anal squamous cell carcinoma

  2023cites this paper
• Preoperative sequential short-course radiation therapy and FOLFOX chemotherapy versus long-course chemoradiotherapy for locally advanced rectal cancer: a multicenter, randomized controlled trial (SOLAR trial)

  2023cites this paper
• Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study

  2023cites this paper
• Effect of Elective Inguinal Irradiation in Low Rectal Cancer with Anal Canal Invasion

  2023cites this paper
• Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

  2023cites this paper
• The role of MRI after neochemoradiotherapy in predicting pathological tumor regression grade and clinical outcome in patients with locally advanced rectal adenocarcinoma

  2023cites this paper
• The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers—Review of the Literature

  2023cites this paper
• Evaluation of Depression, Anxiety, and Sexual Function in Rectal Cancer Patients Before and After Neoadjuvant Chemoradiotherapy

  2023cites this paper
• Bone marrow sparing RapidArc treatment in locally advanced rectal cancer – can it reduce haematological toxicity?

  2023cites this paper
• TUMOUR RESPONSE AND TOXICITY ANALYSIS OF PREOPERATIVE SHORT-COURSE RADIATION THERAPY FOLLOWED BY DELAYED SURGERY IN CARCINOMA RECTUM

  2022cites this paper
• Advances in the treatment of anal squamous cell cancer

  2022cites this paper
• Pelvic Insufficiency Fractures and Bone Pain after Radiation Therapy for Anal Cancer: Relation to Pelvic Bone Dose-Volume Parameters

  2022cites this paper
• Deep learning empowered volume delineation of whole-body organs-at-risk for accelerated radiotherapy

  2022cites this paper
• C-Reactive Protein as Predictive Biomarker for Response to Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Retrospective Study

  2022cites this paper
• Pelvic insufficiency fractures and bone pain after radiotherapy for anal cancer -Relation to pelvic bone dose volume parameters.

  2022cites this paper
• In locally advanced low rectal cancer with anal canal invasion, should elective inguinal irradiation be performed?

  2022cites this paper
• Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response

  2022cites this paper
• Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer

  2022cites this paper
• Correcting rotational error in rectal cancer radiation therapy: Can planning target volume margins be safely reduced?

  2022cites this paper
• Early results from implementation of a ‘watch and wait’ protocol for complete clinical response following chemoradiotherapy for rectal cancer

  2022cites this paper
• CT-Only Radiotherapy: An Exploratory Study for Automatic Dose Prediction on Rectal Cancer Patients Via Deep Adversarial Network

  2022cites this paper
• Overview of Radiation Treatment Volume Variations in Anal Cancer Contouring Guidelines.

  2022cites this paper
• The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy

  2022cites this paper
• Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients

  2022cites this paper
• ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer Using IMRT/IGRT.

  2022cites this paper
• Analysis of Clinicopathological Factors Associated with Radiation-Induced Cystitis in Patients with Cervical Cancer

  2022cites this paper
• Evaluation of the ITV-margin and variables affecting bladder and mesorectal deformation during long course neoadjuvant radiotherapy for rectal cancer.

  2022cites this paper